MondoA drives muscle lipid accumulation and insulin resistance.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
09 07 2019
Historique:
entrez: 10 7 2019
pubmed: 10 7 2019
medline: 22 9 2020
Statut: epublish

Résumé

Obesity-related insulin resistance is associated with intramyocellular lipid accumulation in skeletal muscle. We hypothesized that in contrast to current dogma, this linkage is related to an upstream mechanism that coordinately regulates both processes. We demonstrate that the muscle-enriched transcription factor MondoA is glucose/fructose responsive in human skeletal myotubes and directs the transcription of genes in cellular metabolic pathways involved in diversion of energy substrate from a catabolic fate into nutrient storage pathways including fatty acid desaturation and elongation, triacylglyeride (TAG) biosynthesis, glycogen storage, and hexosamine biosynthesis. MondoA also reduces myocyte glucose uptake by suppressing insulin signaling. Mice with muscle-specific MondoA deficiency were partially protected from insulin resistance and muscle TAG accumulation in the context of diet-induced obesity. These results identify MondoA as a nutrient-regulated transcription factor that under normal physiological conditions serves a dynamic checkpoint function to prevent excess energy substrate flux into muscle catabolic pathways when myocyte nutrient balance is positive. However, in conditions of chronic caloric excess, this mechanism becomes persistently activated leading to progressive myocyte lipid storage and insulin resistance.

Identifiants

pubmed: 31287806
pii: 129119
doi: 10.1172/jci.insight.129119
pmc: PMC6693825
doi:
pii:

Substances chimiques

Arrdc4 protein, mouse 0
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors 0
Insulin 0
Intracellular Signaling Peptides and Proteins 0
Lipids 0
MLXIP protein, human 0
MondoA protein, mouse 0
Transcription Factors 0
Triglycerides 0
Fructose 30237-26-4
Glycogen 9005-79-2
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : K01 DK111715
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK045416
Pays : United States

Références

Diabetologia. 1999 Jan;42(1):113-6
pubmed: 10027589
Metabolism. 2000 Apr;49(4):467-72
pubmed: 10778870
Mol Cell Biol. 2000 Dec;20(23):8845-54
pubmed: 11073985
J Biol Chem. 2001 Oct 26;276(43):39959-67
pubmed: 11522787
Ann N Y Acad Sci. 2002 Jun;967:176-82
pubmed: 12079846
Nat Genet. 2002 Aug;31(4):379-84
pubmed: 12118251
J Biol Chem. 2003 Mar 21;278(12):10297-303
pubmed: 12525490
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82
pubmed: 12629214
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
J Biol Chem. 2004 Jul 30;279(31):32345-53
pubmed: 15166226
J Clin Invest. 2004 Sep;114(6):823-7
pubmed: 15372106
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4807-12
pubmed: 15774581
J Clin Invest. 2006 Jun;116(6):1686-95
pubmed: 16741579
Diabetes. 2007 May;56(5):1228-39
pubmed: 17369521
J Clin Invest. 2007 Sep;117(9):2459-67
pubmed: 17786239
Nat Med. 2007 Oct;13(10):1193-202
pubmed: 17906635
Cell Metab. 2008 Jan;7(1):45-56
pubmed: 18177724
J Clin Invest. 2008 Mar;118(3):956-64
pubmed: 18292813
J Clin Invest. 2008 Mar;118(3):829-38
pubmed: 18317565
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6912-7
pubmed: 18458340
Rapid Commun Mass Spectrom. 2008 Jul;22(13):2115-24
pubmed: 18523984
J Clin Invest. 2009 Mar;119(3):573-81
pubmed: 19188683
Anal Chem. 2009 Jun 1;81(11):4356-68
pubmed: 19408941
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14878-83
pubmed: 19706488
J Biol Chem. 2009 Dec 25;284(52):36312-23
pubmed: 19778901
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nat Med. 2010 Apr;16(4):400-2
pubmed: 20376053
Mol Cell Biol. 2010 Jun;30(12):2887-95
pubmed: 20385767
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nat Commun. 2010 Nov 23;1:127
pubmed: 21119640
PLoS One. 2011;6(7):e21068
pubmed: 21760887
PLoS One. 2011;6(7):e22544
pubmed: 21811631
Biochem Biophys Res Commun. 2011 Sep 9;412(4):638-43
pubmed: 21856285
J Biol Chem. 2011 Nov 4;286(44):38027-34
pubmed: 21908621
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16381-5
pubmed: 21930939
Prog Lipid Res. 2012 Jan;51(1):36-49
pubmed: 22120643
Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E908-16
pubmed: 22850683
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
J Clin Invest. 2013 Jun;123(6):2564-75
pubmed: 23676496
J Biol Chem. 2014 Jan 24;289(4):2250-9
pubmed: 24337569
Biochem J. 2014 Nov 15;464(1):35-48
pubmed: 25145386
Methods Mol Biol. 2014;1198:203-20
pubmed: 25270931
Cancer Cell. 2015 Feb 9;27(2):271-85
pubmed: 25640402
Endocrinology. 2015 Jun;156(6):1982-94
pubmed: 25751637
Endocrinology. 2015 Oct;156(10):3581-95
pubmed: 26248217
Prog Lipid Res. 2016 Jan;61:83-108
pubmed: 26703190
J Clin Invest. 2016 Sep 1;126(9):3567-79
pubmed: 27500491
J Clin Invest. 2016 Nov 1;126(11):4372-4386
pubmed: 27669460
Cell Rep. 2017 Jun 6;19(10):2005-2013
pubmed: 28591573
Diabetologia. 2017 Dec;60(12):2443-2452
pubmed: 28836014
Elife. 2019 Feb 05;8:null
pubmed: 30717828
J Biol Chem. 1995 Feb 3;270(5):2107-11
pubmed: 7836438
Diabetes. 1994 Oct;43(10):1234-41
pubmed: 7926294
Diabetes. 1997 Jun;46(6):983-8
pubmed: 9166669
Diabetes. 1998 Sep;47(9):1519-24
pubmed: 9726244

Auteurs

Byungyong Ahn (B)

Cardiovascular Institute and.

Shibiao Wan (S)

Institute for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Natasha Jaiswal (N)

Institute for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Rick B Vega (RB)

Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona, Orlando, Florida, USA.

Donald E Ayer (DE)

Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

Paul M Titchenell (PM)

Institute for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Xianlin Han (X)

Barshop Institute for Longevity and Aging Studies, Departments of Medicine and Biochemistry, University of Texas Health-San Antonio, San Antonio, Texas, USA.

Kyoung Jae Won (KJ)

Institute for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Daniel P Kelly (DP)

Cardiovascular Institute and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH